In the 2025 financial year, Datwyler generated revenue of CHF 1'100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.

Datwyler has received validation of its short-term, Group-wide greenhouse gas reduction targets by the Science Based Targets initiative (SBTi).

Datwyler expanded its NeoFlex™ range of fully coated plungers with a solution for large-volume cartridges containing 20mL. The launch responds to rising demand for on-body devices for subcutaneous (SC) delivery of biotherapeutics to patients seeking convenient at-home care.

Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group

The Swiss Datwyler site in Schattdorf, Switzerland, took 1st place in the Swiss Arbeitgeber Award 2026 in the category for large companies (250–999 employees).

A year of rapid electrification, rising quality demands and industrial scale-up. Discover the key trends shaping mobility, battery systems and how Datwyler is driving reliability into 2026.

Datwyler has signed an agreement to acquire 51% of Capsul’Invest SA und Brain Corp SA (together operating as Capsul’in), a leading provider of aluminum coffee capsule solutions headquartered in Luxembourg with annual revenues of approximately EUR 90 million.

With its clear focus on high‑value components and strengthening its core competencies, Datwyler is strategically well positioned to benefit from long‑term growth trends.

Datwyler is proud to unveil a new option in its flip cap range: a bio-sourced material for the plastic disc, debuting at CPhI Worldwide 2025.

Wearables have become a major driver of innovation in personalized healthcare in recent years. Learn more about how we turn insights into solutions through our solution design approach on the example of SoftPulse(sup:TM) Flex

Datwyler gained momentum in the first half of 2025 despite a challenging environment.

Datwyler is streamlining its U.S. production network and transferring the production and distribution activities of the Vandalia site in Ohio to two existing Datwyler U.S. sites.

Datwyler strengthens its market position and drives growth by commencing serial supply of premium components for GLP-1 therapies, reflecting its strategic investments and early-stage development partnerships within the rapidly expanding injectable drug market.

Datwyler is a new member of the Circular Rubber Platform, through which it is actively committing to a more sustainable circular economy in the elastomer industry.

Datwyler has been partnering with the non-governmental organization Planet Water for several years to improve access to clean drinking water in Maharashtra, India.

Dätwyler arbeitet seit mehreren Jahren mit der Nichtregierungsorganisation Planet Water zusammen, um den Zugang zu sauberem Trinkwasser in Maharashtra, Indien, zu verbessern.

Datwyler's specialized sealing solutions ensure the efficient and reliable operation of electrolyzers and auxiliary systems.

Datwyler slightly increased its EBIT margin in 2024 despite weak markets and a slight decline in revenue. The transformation program «ForwardNow» will accelerate the planned profitable growth.